1.77
                                            Finanzdaten der Sunshine Biopharma Inc-Aktie (SBFM)
Gewinn- und Verlustrechnung
                
            Vierteljährlich
                
            
        *Alle Zahlen in Millionen
    
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 
| Revenues | 
                                            
                                        5.72%
                                     9.4102 | 8.9013 | 9.595 | 8.4352 | 9.3031 | 
| Cost Of Revenue | 
                                            
                                        2.97%
                                     5.9874 | 6.1709 | 6.5019 | 5.569 | 6.9468 | 
| Gross Profit | 
                                            
                                        25.36%
                                     3.4229 | 2.7304 | 3.093 | 2.8662 | 2.3563 | 
|  | 
                                            
                                        36.05%
                                     5.4775 | 4.0262 | 5.1308 | 3.9725 | 3.6245 | 
| Benefits Costs and Expenses | 
                                            
                                        12.54%
                                     11.39 | 10.12 | 11.88 | 9.4178 | 10.14 | 
| Costs And Expenses | 
                                            
                                        12.54%
                                     11.39 | 10.12 | 11.88 | 9.4178 | 10.14 | 
| Operating Income/Loss | 
                                            
                                        58.57%
                                     -2.0547 | -1.2958 | -2.0377 | -1.1064 | -1.2683 | 
| Nonoperating Income/Loss | 
                                            
                                        1.53%
                                     0.0747 | 0.0758 | -0.2492 | 0.1238 | 0.4303 | 
| Income/Loss From Continuing Operations Before Tax | 
                                            
                                        62.30%
                                     -1.98 | -1.2199 | -2.2869 | -0.9826 | -0.838 | 
| Income Tax Expense/Benefit | 
                                            
                                        420.82%
                                     -0.2092 | -0.0402 | -0.1287 | 0.2152 | -0.3437 | 
| Income/Loss From Continuing Operations After Tax | 
                                            
                                        50.10%
                                     -1.7708 | -1.1798 | -2.1582 | -1.1978 | -0.4943 | 
|  | 
                                            
                                        50.10%
                                     -1.7708 | -1.1798 | -2.1582 | -1.1978 | -0.4943 | 
| Preferred Stock Dividends And Other Adjustments | 1.1798 | - | - | - | - | 
| Attributable To Noncontrolling Interest | - | - | - | - | - | 
| Basic Average Shares | 
                                            
                                        66.32%
                                     4.4961 | 2.7033 | 0.4831 | 1.2676 | 0.0497 | 
| Diluted Average Shares | 
                                            
                                        33.34%
                                     3.6047 | 2.7033 | -1.2569 | 1.2676 | 0.0497 | 
| Basic Earnings Per Share | 
                                            
                                        11.36%
                                     -0.39 | -0.44 | 6.29 | -0.94 | -9.94 | 
| Diluted Earnings Per Share | 
                                            
                                        86.36%
                                     -0.82 | -0.44 | - | - | - | 
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | 1.1798 | - | - | - | - | 
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):
                 
            
         
                     
                             Holen Sie sich die Stockscreener-App
                    Holen Sie sich die Stockscreener-App
                